Patients with polycythemia vera and essential thrombocythemia with prior malignancy do not have significantly worse outcome

Mohamad Cherry, Marylou Cardenas-Turanzas, Hannah Pham, Hagop Kantarjian, Jorge Cortes, Sherry Pierce, Lingsha Zhou, Srdan Verstovsek

Research output: Contribution to journalArticle

Abstract

The clinical relevance of prior malignancy (PM) in patients with essential thrombocythemia (ET) and polycythemia vera (PV) is largely unknown. We retrospectively evaluated 437 patients (ET, n= 263; PV, n= 174) treated at MD Anderson between 1960 and 2010. Forty-four patients had PM (ET, 10%; PV, 11%), with median time to diagnosis of 66 months. PM was not associated with abnormal cytogenetics, JAK2-mutation frequency, blood-cell counts or progression to acute leukemia or myelofibrosis. In multivariate analysis, only older age and high LDH levels were associated with worse OS. In conclusion, PM does not predict worse outcomes for patients with ET and PV.

Original languageEnglish (US)
Pages (from-to)1472-1476
Number of pages5
JournalLeukemia Research
Volume37
Issue number11
DOIs
StatePublished - Nov 1 2013
Externally publishedYes

Fingerprint

Essential Thrombocythemia
Polycythemia Vera
Neoplasms
Primary Myelofibrosis
Blood Cell Count
Mutation Rate
Cytogenetics
Leukemia
Multivariate Analysis

Keywords

  • Essential thrombocythemia
  • Myeloproliferative disorders
  • Polycythemia vera
  • Prior malignancy
  • Transformation to acute leukemia
  • Transformation to myelofibrosis

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Patients with polycythemia vera and essential thrombocythemia with prior malignancy do not have significantly worse outcome. / Cherry, Mohamad; Cardenas-Turanzas, Marylou; Pham, Hannah; Kantarjian, Hagop; Cortes, Jorge; Pierce, Sherry; Zhou, Lingsha; Verstovsek, Srdan.

In: Leukemia Research, Vol. 37, No. 11, 01.11.2013, p. 1472-1476.

Research output: Contribution to journalArticle

Cherry, M, Cardenas-Turanzas, M, Pham, H, Kantarjian, H, Cortes, J, Pierce, S, Zhou, L & Verstovsek, S 2013, 'Patients with polycythemia vera and essential thrombocythemia with prior malignancy do not have significantly worse outcome', Leukemia Research, vol. 37, no. 11, pp. 1472-1476. https://doi.org/10.1016/j.leukres.2013.08.002
Cherry, Mohamad ; Cardenas-Turanzas, Marylou ; Pham, Hannah ; Kantarjian, Hagop ; Cortes, Jorge ; Pierce, Sherry ; Zhou, Lingsha ; Verstovsek, Srdan. / Patients with polycythemia vera and essential thrombocythemia with prior malignancy do not have significantly worse outcome. In: Leukemia Research. 2013 ; Vol. 37, No. 11. pp. 1472-1476.
@article{c56efd9c8fd54336b17cbd319cc694c4,
title = "Patients with polycythemia vera and essential thrombocythemia with prior malignancy do not have significantly worse outcome",
abstract = "The clinical relevance of prior malignancy (PM) in patients with essential thrombocythemia (ET) and polycythemia vera (PV) is largely unknown. We retrospectively evaluated 437 patients (ET, n= 263; PV, n= 174) treated at MD Anderson between 1960 and 2010. Forty-four patients had PM (ET, 10{\%}; PV, 11{\%}), with median time to diagnosis of 66 months. PM was not associated with abnormal cytogenetics, JAK2-mutation frequency, blood-cell counts or progression to acute leukemia or myelofibrosis. In multivariate analysis, only older age and high LDH levels were associated with worse OS. In conclusion, PM does not predict worse outcomes for patients with ET and PV.",
keywords = "Essential thrombocythemia, Myeloproliferative disorders, Polycythemia vera, Prior malignancy, Transformation to acute leukemia, Transformation to myelofibrosis",
author = "Mohamad Cherry and Marylou Cardenas-Turanzas and Hannah Pham and Hagop Kantarjian and Jorge Cortes and Sherry Pierce and Lingsha Zhou and Srdan Verstovsek",
year = "2013",
month = "11",
day = "1",
doi = "10.1016/j.leukres.2013.08.002",
language = "English (US)",
volume = "37",
pages = "1472--1476",
journal = "Leukemia Research",
issn = "0145-2126",
publisher = "Elsevier Limited",
number = "11",

}

TY - JOUR

T1 - Patients with polycythemia vera and essential thrombocythemia with prior malignancy do not have significantly worse outcome

AU - Cherry, Mohamad

AU - Cardenas-Turanzas, Marylou

AU - Pham, Hannah

AU - Kantarjian, Hagop

AU - Cortes, Jorge

AU - Pierce, Sherry

AU - Zhou, Lingsha

AU - Verstovsek, Srdan

PY - 2013/11/1

Y1 - 2013/11/1

N2 - The clinical relevance of prior malignancy (PM) in patients with essential thrombocythemia (ET) and polycythemia vera (PV) is largely unknown. We retrospectively evaluated 437 patients (ET, n= 263; PV, n= 174) treated at MD Anderson between 1960 and 2010. Forty-four patients had PM (ET, 10%; PV, 11%), with median time to diagnosis of 66 months. PM was not associated with abnormal cytogenetics, JAK2-mutation frequency, blood-cell counts or progression to acute leukemia or myelofibrosis. In multivariate analysis, only older age and high LDH levels were associated with worse OS. In conclusion, PM does not predict worse outcomes for patients with ET and PV.

AB - The clinical relevance of prior malignancy (PM) in patients with essential thrombocythemia (ET) and polycythemia vera (PV) is largely unknown. We retrospectively evaluated 437 patients (ET, n= 263; PV, n= 174) treated at MD Anderson between 1960 and 2010. Forty-four patients had PM (ET, 10%; PV, 11%), with median time to diagnosis of 66 months. PM was not associated with abnormal cytogenetics, JAK2-mutation frequency, blood-cell counts or progression to acute leukemia or myelofibrosis. In multivariate analysis, only older age and high LDH levels were associated with worse OS. In conclusion, PM does not predict worse outcomes for patients with ET and PV.

KW - Essential thrombocythemia

KW - Myeloproliferative disorders

KW - Polycythemia vera

KW - Prior malignancy

KW - Transformation to acute leukemia

KW - Transformation to myelofibrosis

UR - http://www.scopus.com/inward/record.url?scp=84886772830&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84886772830&partnerID=8YFLogxK

U2 - 10.1016/j.leukres.2013.08.002

DO - 10.1016/j.leukres.2013.08.002

M3 - Article

C2 - 23993426

AN - SCOPUS:84886772830

VL - 37

SP - 1472

EP - 1476

JO - Leukemia Research

JF - Leukemia Research

SN - 0145-2126

IS - 11

ER -